Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
Promising drug combination for advanced prostate cancer
A new drug combination may be effective in treating men with metastatic prostate cancer.
Lung cancer: Adaptimmune initiates Phase I / II trial evaluating its Affinity enhanced Tcell therapy targeting NY-ESO-1
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of engineered T-cell therapy to treat cancer, has announced that it has initiated a study of its affinity enhanced T-cell therapy...
Pioneering 'Science to Survive' pipeline gives cancer patients hope for a brighter future
Potentially life-saving therapies for cancer will be accelerated into clinical trials more quickly due to a pioneering project launched by scientists and clinicians at the University of Sheffield.
Autifony Therapeutics initiates Phase I study of AUT00206, a novel treatment approach for schizophrenia
Autifony Therapeutics Limited, which is pioneering the development of novel pharmaceutical treatments for hearing loss and other serious brain disorders, today announced the start of Phase I...
Genmab announces ofatumumab Phase III study in follicular lymphoma to be stopped following planned interim analysis
Genmab A/S has announced that the Phase III study of single agent ofatumumab compared to single agent rituximab in patients with follicular non-Hodgkin's lymphoma (NHL) that has relapsed at least 6...
VolitionRx demonstrates NUQ blood test detects lung cancers with more than 90% accuracy
VolitionRx Limited has announced interim data demonstrating its NuQ® blood tests have accurately detected more than 90% of lung cancer cases in a study of 73 patients.
Combination of pills for advanced skin cancer extends survival compared with previous monotherapy
The combination of cobimetinib and Zelboraf® (vemurafenib) has been shown to extend the lives of previously untreated patients with advanced skin cancer to nearly two years (22.
Data show tolerability and effectiveness of SIMPONI in treating patients with active non-radiographic axial spondyloarthritis
MSD (Merck & Co., Inc., Kenilworth, New Jersey, USA), recently announced long-term tolerability and efficacy results from the open-label extension1 of the GO-AHEAD study, a randomised, double-blind...
C-EARLY: certolizumab pegol effective in early rheumatoid arthritis
A study presented at the American College of Rheumatology Annual Meeting suggests certolizumab pegol is beneficial for patients with early rheumatoid arthritis.
Quark Pharmaceutical announces initiation of patient recruitment for global pivotal study of QPI-1007 in NAION
Quark Pharmaceuticals, Inc., a late clinical-stage pharmaceutical company, who is a leader in the discovery and development of novel RNA interference (RNAi)-based therapeutics, has announced that...
Will immunotherapy add value to chemotherapy for HER-2 positive gastric cancer?
The prognosis for patients with gastric cancer is poor. In western countries even patients with localized gastric or gastro-esophageal junction adenocarcinoma are faced with 5-year survival rates of...
Myocardial infarction: PEGASUS-TIMI 54 sub-analysis outlines long-term tolerability data for BRILINTA
AstraZeneca has announced results of a sub-analysis of the PEGASUS-TIMI 54 study, which evaluated reasons and rates for discontinuation of BRILINTA® (ticagrelor) in patients with a history of...
Rutgers Cancer Institute of New Jersey collaborates with Big Ten Cancer Research Consortium on clinical trial for metastatic kidney cancer
In conjunction with the Big Ten Cancer Research Consortium (BTCRC), Rutgers Cancer Institute of New Jersey has opened a clinical trial for patients with kidney cancer that has spread to other parts...
Mallinckrodt study shows Acthar reduces disease activity in patients with persistently active systemic lupus erythematosus
Data presented by researchers for Mallinckrodt plc, a leading specialty biopharmaceutical company, suggest that H.P.
Astrazeneca presents positive update on lesinurad renal data in gout patients
AstraZeneca has announced positive subanalysis data of the Phase III lesinurad studies (CLEAR1, CLEAR2 and CRYSTAL) for the treatment of hyperuricemia associated with gout, in combination with a...
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2015
Content Management / Website Design by Tresware